Novartis AG ADR [NVS] stock is trading at $109.22, down -0.12%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The NVS shares have gain 3.59% over the last week, with a monthly amount glided 9.19%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Novartis AG ADR [NYSE: NVS] stock has seen the most recent analyst activity on February 13, 2025, when UBS downgraded its rating to a Neutral. On February 04, 2025, upgrade upgraded it’s rating to Buy. HSBC Securities downgraded its rating to a Reduce. BofA Securities downgraded its rating to a Neutral and reduced its price target to $130 on September 11, 2024. Goldman downgraded its rating to Neutral for this stock on September 05, 2024. In a note dated September 03, 2024, Jefferies downgraded an Hold rating on this stock.
Novartis AG ADR [NVS] stock has fluctuated between $92.35 and $120.92 over the past year. Currently, Wall Street analysts expect the stock to reach $120.5 within the next 12 months. Novartis AG ADR [NYSE: NVS] shares were valued at $109.22 at the most recent close of the market. An investor can expect a potential return of 10.33% based on the average NVS price forecast.
Analyzing the NVS fundamentals
Novartis AG ADR [NYSE:NVS] reported sales of 50.32B for the trailing twelve months, which represents a growth of 15.14%. Gross Profit Margin for this corporation currently stands at 0.75% with Operating Profit Margin at 0.28%, Pretax Profit Margin comes in at 0.26%, and Net Profit Margin reading is 0.23%. To continue investigating profitability, this company’s Return on Assets is posted at 0.12, Equity is 0.28 and Total Capital is 0.2. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.71.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 108.75 points at the first support level, and at 108.27 for the second support level. However, for the 1st resistance point, the stock is sitting at 109.79, and for the 2nd resistance point, it is at 110.35.
Ratios To Look Out For
For context, Novartis AG ADR’s Current Ratio is 1.04. Also, the Quick Ratio is 0.84, while the Cash Ratio stands at 0.4. Considering the valuation of this stock, the price to sales ratio is 4.29, the price to book ratio is 4.90 and price to earnings (TTM) ratio is 18.60.
Transactions by insiders
Recent insider trading involved Kowalski Robert William, Officer, that happened on Aug 12 ’24 when 6566.0 shares were purchased.
